The future of cardiac PET


Positron SEC Form 15

Positron is pleased to report that over the past 12 month it has made significant progress in strengthening the Company’s operations, financials and all aspects key to the future of our business.

One of our key initiatives is full compliance with SEC rules and regulations. On May 2, 2019 Positron filed Form 15 with the SEC for voluntary suspension of reporting duties.

This voluntary action was prudent and a positive first step in the process of returning to a fully reporting publicly traded company in the future; a status we aim to achieve in the coming year. 

Print this page